Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment

Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp

(2013) N. K. Stepto et al.   HUMAN REPRODUCTION

Cardiometabolic Aspects of the Polycystic Ovary Syndrome

(2012) Harpal S. Randeva et al.   ENDOCRINE REVIEWS

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

(2012) Evanthia Diamanti-Kandarakis et al.   ENDOCRINE REVIEWS

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

(2012) B. O. Yildiz et al.   HUMAN REPRODUCTION

What Is “Metabolically Healthy Obesity”?: From Epidemiology to Pathophysiological Insights

(2012) Jean-Pierre Després   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia

(2012) Jacqueline A Boyle et al.   MEDICAL JOURNAL OF AUSTRALIA

The Different Phenotypes of Polycystic Ovary Syndrome: No Advantages for Identifying Women with Aggravated Insulin Resistance or Impaired Lipids

(2011) S. Cupisti et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk

(2011) M. C. Amato et al.   HUMAN REPRODUCTION

Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population

(2011) Marco C Amato et al.   Lipids in Health and Disease

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

(2011) Mark O. Goodarzi et al.   Nature Reviews Endocrinology

Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk

(2010) M. C. Amato et al.   DIABETES CARE

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society

(2010) Robert A. Wild et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

(2009) W. A. March et al.   HUMAN REPRODUCTION

The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome

(2008) Marco Calogero Amato et al.   CLINICAL ENDOCRINOLOGY

Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels

(2008) K. M. Utzschneider et al.   DIABETES CARE

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

(2008) Ricardo Azziz et al.   FERTILITY AND STERILITY

Insulin resistance and polycystic ovary syndrome

(2008) Aldo Galluzzo et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Cardiometabolic features of polycystic ovary syndrome

(2008) Leslie K Hoffman et al.   Nature clinical practice. Endocrinology & metabolism